Diagnostic Microbiology & Infectious Disease
Volume 45, Issue 1 , Pages 23-27 , January 2003

Detection of group B streptococcal bacteremia in simulated intrapartum antimicrobial prophylaxis

  • Katherine K. Hsu

      Affiliations

    • Maxwell Finland Laboratory for Infectious Diseases, Boston University School of Medicine and Boston Medical Center, Boston, MA 02118, USA
    • Department of Pediatrics, Boston University School of Medicine and Boston Medical Center, Boston, MA 02118, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1-617-414-6394; fax: +1-617-414-7230.
    • ,
  • Stephen I. Pelton

      Affiliations

    • Maxwell Finland Laboratory for Infectious Diseases, Boston University School of Medicine and Boston Medical Center, Boston, MA 02118, USA
    • Department of Pediatrics, Boston University School of Medicine and Boston Medical Center, Boston, MA 02118, USA
    • ,
  • Daniel S. Shapiro

      Affiliations

    • Maxwell Finland Laboratory for Infectious Diseases, Boston University School of Medicine and Boston Medical Center, Boston, MA 02118, USA
    • Departments of Medicine and Pathology and Laboratory Medicine, Boston University School of Medicine and Boston Medical Center, Boston, MA 02118, USA

Received 28 January 2002 ,Accepted 19 August 2002.

References 

  1. ACOG Committee on Obstetric Practice.. Prevention of early-onset group B streptococcal disease in newborns. Washington, DC: American College of Obstetricians and Gynecologists; 1996;
  2. AAP Committee on Infectious Diseases and Committee on Fetus and Newborn. Revised guidelines for prevention of early-onset group B streptococcal (GBS) disease. Pediatrics. 1997;99:489–496
  3. Bray RE, Boe RW, Johnson WL. Transfer of ampicillin into fetus and amniotic fluid from maternal plasma in late pregnancy. Am J Obstet Gynecol. 1966;96:938–942
  4. Centers for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease (a public health perspective). MMWR. 1996;45:1–24
  5. Centers for Disease Control and Prevention. Erratum: Vol. 45, No. RR-7. MMWR. 1996;45:679
  6. Centers for Disease Control and Prevention. Adoption of hospital policies for prevention of perinatal group B streptococcal disease—United States, 1997. MMWR. 1998;47:665–670
  7. Cooper MD, Keeney RE, Lyons SF, Cheatle EL. Synergistic effects of ampicillin-aminoglycoside combinations on group B streptococci. Antimicrob Agents Chemother. 1979;15:484–486
  8. Dunne WM, Tillman J, Havens PL. Assessing the need for anaerobic medium for the recovery of clinically significant blood culture isolates in children. Pediatr Infect Dis J. 1994;13:203–206
  9. Eisenach K, Dyke J, Boehme M, Johnson B, Cook MB. Pediatric blood culture evaluation of the BACTEC PEDS Plus and the Du Pont Isolator 1.5 systems. Diagn Microbiol Infect Dis. 1992;15:225–231
  10. Kenagy DN, Baker CJ. Antibiotic therapy in neonates whose mothers have received intrapartum group B streptococcal chemoprophylaxis. Pediatr Infect Dis J. 1990;9:149–150
  11. Kiefer LK, Rubin A, McCoy JB, Foltz EL. Placental transfer of erythromycin. Am J Obstet Gynecol. 1955;69:174–177
  12. MacAulay MA, Abou-Sabe M, Charles D. Placental transfer of ampicillin. Am J Obstet Gynecol. 1966;96:943–950
  13. Morello JA, Matushek SM, Dunne WM, Hinds DB. Performance of a BACTEC nonradiometric medium for pediatric blood cultures. J Clin Microbiol. 1991;29:359–362
  14. Pacifici GM, Nottoli R. Placental transfer of drugs administered to the mother. Clin Pharmacokin. 1995;28:235–269
  15. Peralta-Carcelen M, Fargason CA, Cliver SP, Cutter GR, Gigante J, Goldenberg RL. Impact of maternal group B streptococcal screening on pediatric management in full-term neonates. Arch Pediatr Adol Med. 1996;150:802–808
  16. Philipson A, Sabath LD, Charles D. Transplacental passage of erythromycin and clindamycin. NEJM. 1973;288:1219–1221
  17. Schauf V, Deveikis A, Riff L, Serota A. Antibiotic-killing kinetics of group B streptococci. J Pediatr. 1976;89:194–198
  18. Spaargaren J, vanBoven CPA, Voorn GP. Effectiveness of resins in neutralizing antibiotic activities in Bactec Plus Aerobic/F culture medium. J Clin Microbiol. 1998;36:3731–3733
  19. Swingle HM, Bucciarelli RL, Ayoub EM. Synergy between penicillins and low concentrations of gentamicin in the killing of group B streptococci. J Infect Dis. 1985;152:515–520
  20. Weinstein AJ, Gibbs RS, Gallagher M. Placental transfer of clindamycin and gentamicin in term pregnancy. Am J Obstet Gynecol. 1976;124:688–691
  21. Welby PL, Zusag TM, Storch GA. Comparison of the Bactec Peds Plus pediatric blood culture vial with Roche pediatric Septi-Chek for blood cultures from pediatric patients. J Clin Microbiol. 1992;30:1361–1362
  22. Yoshioka H, Monma T, Matsuda S. Placental transfer of gentamicin. J Pediatr. 1972;80:121–123
  23. Yow MD, Mason EO, Leeds LJ, Thompson PK, Clark DJ, Gardner SE. Ampicillin prevents intrapartum transmission of group B streptococcus. JAMA. 1979;241:1245–1247
  24. Zaidi AKM, Knaut AL, Mirrett S, Reller LB. Value of routine anaerobic blood cultures for pediatric patients. J Pediatr. 1995;127:263–268
  25. Zaidi AK, Mirrett S, McDonald JC, Rubin EE, McDonald LC, Weinstein MP, et al. Controlled comparison of bioMerieux VITAL and BACTEC NR-660 systems for detection of bacteremia and fungemia in pediatric patients. J Clin Microbiol. 1997;35:2007–2012

PII: S0732-8893(02)00480-7

doi: 10.1016/S0732-8893(02)00480-7

Diagnostic Microbiology & Infectious Disease
Volume 45, Issue 1 , Pages 23-27 , January 2003

Article Tools

* Image Usage & Resolution